Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|May 15, 2015
Strategies for building reference standards for autoantibodiesJoanna Sheldon, Alessandra Dellavance
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Detection of Autoantibodies by Indirect Immunofluorescence Cytochemistry on Hep-2 CellsAlessandra Dellavance, Luis Eduardo Coelho Andrade
Revista Da Associacao Medica Brasileira (1992)|October 24, 2007
[Relevance of the immunofluorescence pattern for interpretation of the ANA test--the case of the dense fine speckled pattern]Alessandra Dellavance, Paulo Guilherme Leser, Luís Eduardo Coelho Andrade
Best Practice & Research. Clinical Rheumatology|May 26, 2004
Laboratory testing in autoimmune rheumatic diseasesJoanna Sheldon
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 6, 2014
The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: proposal of reliable and feasible strategiesKaline Medeiros Costa Pereira, Alessandra Dellavance, Luis Eduardo Coelho Andrade
Auto- Immunity Highlights|April 8, 2020
Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodiesDanielle Cristiane Baldo, Alessandra Dellavance, Maria Lucia Gomes Ferraz, et al.
Clinical Chemistry and Laboratory Medicine|July 7, 2020
Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosusMônica Simon Prado, Alessandra Dellavance, Silvia Helena Rodrigues, et al.
Annals of Clinical Biochemistry|May 12, 2017
Electrophoretic patterns post daratumumabJoanna Sheldon, Rachel D Wheeler, Ray Powles
Annals of Clinical Biochemistry|November 21, 2017
Large abnormal peak on capillary zone electrophoresis due to contrast agentRachel D Wheeler, Liqun Zhang, Joanna Sheldon
Arthritis and Rheumatism|October 19, 2010
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseasesHenrique A Mariz, Emília I Sato, Silvia H Barbosa, et al.
Pageof 6